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Abstract
DNA copy number variants (CNVs) that alter the copy number of a particular DNA segment
in the genome play an important role in human phenotypic variability and disease suscepti-
bility. A number of CNVs overlapping with genes have been shown to confer risk to a variety
of human diseases thus highlighting the relevance of addressing the variability of CNVs at a
higher resolution. So far, it has not been possible to deterministically infer the allelic compo-
sition of different haplotypes present within the CNV regions. We have developed a novel
computational method, called PiCNV, which enables to resolve the haplotype sequence
composition within CNV regions in nuclear families based on SNP genotyping microarray
data. The algorithm allows to i) phase normal and CNV-carrying haplotypes in the copy
number variable regions, ii) resolve the allelic copies of rearranged DNA sequence within
the haplotypes and iii) infer the heritability of identified haplotypes in trios or larger nuclear
families. To our knowledge this is the first program available that can deterministically
phase null, mono-, di-, tri- and tetraploid genotypes in CNV loci. We applied our method to
study the composition and inheritance of haplotypes in CNV regions of 30 HapMap Yoruban
trios and 34 Estonian families. For 93.6% of the CNV loci, PiCNV enabled to unambiguously
phase normal and CNV-carrying haplotypes and follow their transmission in the corre-
sponding families. Furthermore, allelic composition analysis identified the co-occurrence of
alternative allelic copies within 66.7% of haplotypes carrying copy number gains. We also
observed less frequent transmission of CNV-carrying haplotypes from parents to children
compared to normal haplotypes and identified an emergence of several de novo deletions
and duplications in the offspring.
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Introduction
DNA copy number variation is a subtype of structural genetic variation that may increase the
copy number of a particular DNA segment from normal two copies per diploid genome (dip-
loid copy number, CN = 2) to more than two (diploid CN>2; duplication, triplication, etc.) or
decrease to less than two (CN<2; deletion) copies. In the human genome, CNV lengths typical-
ly range from few kilo-bases to several mega-bases. It is estimated that they cumulatively cover
at least 5% of the human genome [1–4] and suggested that they play a major role in different
human phenotypic traits, including disease susceptibility [5, 6]. CNVs can overlap with genes
and, by changing DNAmethylation and gene expression patterns or altering coding sequences
of these genes, have functional and phenotypic consequences [7–9]. In their high resolution
study of HapMap individuals, Conrad et al. found that as much as 13% of RefSeq genes over-
lapped validated CNVs [3].
A multitude of phenotypes and diseases have already been robustly associated with CNVs
(reviewed in References [10–12]) and many disease-associated copy number variants of high
penetrance are known [13–16]. However, the penetrance is not complete for most CNV loci as-
sociated so far [17–20], possibly due to epigenetic modifications, other genetic variants in the vi-
cinity, modifier genes and regulatory elements (reviewed by Cooper et al.) [21], and potentially
also due to allele dosage effects in combination with alternative allelic copies present within the
CNV regions. It is plausible that variable allele dosage of other types of genetic variants with di-
rectly functional effect (e.g. SNPs—single nucleotide variants in coding sequence) found within
the copy number altered DNA segments could modulate the severity of a certain phenotype. So
far, majority of studies have disregarded the allelic nature of CNVs and have only considered
the total estimated number of copies on two homologous chromosomes (CN = 0, 1, 2, 3, etc.)
[19, 22–25] or the continuous normalised microarray intensity data [8, 26, 27].
The ability to phase and differentiate between normal haplotypes (with haploid copy num-
ber of 1; cn = 1) and CNV-carrying haplotypes (haploid copy number cn = 0 or cn>1) with dif-
ferent allelic composition (Fig 1) along with their parental origin would enable new, possibly
more specific and therefore more powerful association analyses with phenotypic traits [6, 28].
By ‘normal haplotype’ we hereinafter denote a continuous chromosomal segment carrying one
copy of a certain unique sequence per homologous chromosome and by ‘CNV-carrying haplo-
type’ we denote a continuous chromosomal region carrying no or more than one copy of a cer-
tain (otherwise unique) sequence per homologous chromosome. Just as the phase information
has been shown to be important in case of SNP variants [29, 30], elucidating the exact distribu-
tion of copies of a particular DNA sequence on two sets of chromosomes may prove beneficial
in case of CNVs [6, 31].
In addition to the accustomed two-letter SNP genotypes, the genome-wide genotyping mi-
croarray data allows to infer null, mono-, tri- and tetraploid ‘CNV genotypes’ [32–35] and per-
form phasing of the exact haplotypes within each CNV region. In spite of the fact that there are
several methods and algorithms that can statistically phase CNV-carrying haplotypes and infer
chromosome-specific copy number [36–43], there are no computational methods available that
would also enable deterministic phasing of the exact allelic composition of haplotypes in CNV
regions of studied individuals. In order to further improve CNV-based studies, it would be of ut-
most importance to develop new methods and algorithms that could accurately infer the chro-
mosome-specific copy number and also allelic composition at CNV regions [5, 31, 44–46].
In the current study, we developed a computational method PiCNV for phasing of normal
and variant-carrying haplotypes within CNV regions to be applied on genome-wide data
of trios and larger nuclear families. We aimed to determine, how often it is unambiguously pos-
sible to infer the exact haplotypes and alternative allelic copies within CNV regions and follow
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their transmission in nuclear families. Exact haplotype phasing within CNV regions also al-
lowed us to study the inheritance patterns between normal and CNV-carrying haplotypes and
between haplotypes carrying deletions and duplications.
Results
PiCNV, computational method for phasing normal and CNV-carrying
haplotypes of CNV regions in families
We have developed a computational method that can deterministically phase normal (cn = 1)
and CNV-carrying (deletion, cn = 0; or copy number gain, cn>1) haplotypes in CNV regions
in nuclear families based on genotype and copy number estimates from SNP microarray data
(Fig 1). Our algorithm (called PiCNV for ‘Phasing and inheritance of Copy Number Variants’)
works with the parsed output of widely used CNV calling algorithms like PennCNV [47],
QuantiSNP [33] and Fawkes [34]. In addition to CNV calling from genotyping microarray
data, these algorithms can infer the diploid allelic composition (referred to as ‘CNV genotype’
or ‘CNV-based SNP genotype’) for each SNP marker within CNV regions. As regular two-let-
ter genotypes (e.g. ‘AA’ or ‘AB’), these null, mono-, tri- and tetraploid genotypes (e.g. ‘–‘, ‘A’,
‘ABB’ and ‘ABBB’, respectively) are inferred from B-allele frequency (BAF) data and represent
Fig 1. Phasing and allelic composition of normal and CNV-carrying haplotypes on parental homologous chromosomes. A chromosomal region
involving copy number variation is denoted with ‘R2’. In the given example, father is the carrier of two normal haplotypes of ‘R2’ on chromosomes P1 and P2
(diploid copy number of ‘R2’, CN = 2), whereas mother has a combination of a duplication-carrying (on M1) and normal (M2) haplotypes (diploid copy number
of ‘R2’, CN = 3). Haplotype-informative SNP genotypes in ‘R2’ sequence that can be used for phasing and determining the parental origin (in offspring) of
given normal and CNV-carrying haplotypes are given in bold letters and genotypes that are polymorphic between normal or duplication-carrying parental
haplotypes are indicated with dashed rectangles. The duplication-carrying haplotype on maternal M1 chromosome is composed of two allelic copies of the
sequence ‘R2’ distinguished by genotype variability at position SNP7 (polymorphic SNP variantwithin the duplication-carrying haplotype), indicated with
dotted rectangle.
doi:10.1371/journal.pone.0122713.g001
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the total allelic composition from both homologous chromosomes of a studied individual [32–
34, 48]. By using CNV calls, haplotype-informative genotypes (polymorphic in the parents)
and user-defined family structure, our algorithm will phase the allelic composition within each
CNV region in studied families (Figs 1 and 2).
PiCNV works by examining consecutive regular (two-letter) and CNV genotypes in each
family member in a CNV region present in any member of the corresponding family. It will test
all possible haplotypes and their transmission according to all Mendelian inheritance scenarios
in the studied CNV locus in a given family. If the family includes more than one child, all chil-
dren will be considered simultaneously in this step and conclusively, for each CNV locus,
PiCNV will select these normal and deletion- or duplication-carrying haplotypes and transmis-
sion scenarios that can explain the allelic composition for every member of the corresponding
family (Fig 3). In case it is not possible to explain the allelic composition in an offspring by Men-
delian transmission of parental haplotypes, non-Mendelian transmission scenarios—de novo
deletion/duplication events and uniparental isodisomy/heterodisomy are automatically consid-
ered. Provided informative genotypes are present in parental haplotypes, PiCNV is also able to
determine on which parental chromosome the de novo event has occurred. Complete source
code and Linux binaries for PiCNV are available from http://bioinfo.ut.ee/picnv.
Testing of PiCNV—CNV calling and confirmation in two microarray
datasets
To test our phasing methodology and PiCNV algorithm, we analysed two family-based datasets
(Table 1). First, we analysed publicly available high-resolution microarray (Illumina
Human1M) data generated by Itsara et al. [49] for 30 HapMap Yoruban (HapMap YRI) moth-
er-father-child trios from the International HapMap Project [50, 51]. Microarray data were
analysed with QuantiSNP [33] and PennCNV [47] algorithms to call CNVs (S1 Fig). These
calls were merged (as intersection of overlapping QuantiSNP and PennCNV calls) for each in-
dividual and only CNVs that were similarly called (same type overlapping variant calls) were
considered. In order to achieve high-quality CNV dataset, these CNV calls were further con-
firmed with an independent set of validated CNV calls from custom Affymetrix high-resolu-
tion microarrays for the same Yoruban individuals [52]. Only CNVs that were similarly called
in the same individuals in both datasets were considered and further converged into 1364 CNV
regions in families that were used in the following analyses (S2 Table). In each such CNV re-
gion, at least one member of the corresponding family had a confirmed CNV while family
members with no CNVs were proven to have no variant calls in any of the datasets.
Secondly, we analysed low-resolution microarray (Illumina HumanCNV370K) data for 34 Es-
tonian families from the Estonian Genome Center of University of Tartu (EGCUT dataset) con-
sisting of 22 mother-father-child trios and 12 larger families (Table 1). CNVs were called as in the
HapMap YRI data, converged in families and further visually confirmed from the microarray sig-
nal intensity data. This resulted in 146 visually confirmed CNV regions in families that were used
in the following analyses (S2 Table). Out of 146 CNV regions, 12 randomly selected and 8 puta-
tive de novo CNV regions were validated by quantitative real-time PCR in all members of the re-
spective families (S1 Table). According to these validation experiments, the false positive rate of
CNV calling was estimated at 11% and false negative rate at 9% for the EGCUT CNV dataset.
Computational phasing of CNV regions in HapMap YRI and EGCUT
datasets
Based on the occurrences of CNVs among parents in each CNV region and family, we divided
the CNV regions and the corresponding transmission events into three groups (S1 Fig). Firstly,
CNV Haplotype Phasing in Families
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Fig 2. Computational phasing of normal and CNV-carrying haplotypes. (A) First, CNV and regular two-
letter genotypes are collected from the QuantiSNP output for each family member at a locus of interest. (B)
Next, markers that have any low-confidence genotype calls or the call could not have been made (‘NC’
genotypes, e.g. marker rs10801575, marked with the red background) and monomorphic markers that are
not informative for haplotype phasing in the studied region (e.g. marker rs7517836; marked with the red
CNV Haplotype Phasing in Families
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all CNV regions with only one parent carrying a CNV (irrespective whether it was transmitted
to their offspring or not) were assigned to group A. Secondly, all CNV regions where both pa-
rents were carriers of a CNV in the same locus were assigned to group B. Finally, all putative de
novo CNVs with no carriers among the parents but with at least one child as a carrier of a CNV
in the corresponding locus were assigned to group C.
The subsequent three groups of CNV regions were subjected to haplotype phasing using the
PiCNV program in both HapMap YRI and EGCUT datasets combined. The PiCNV was able to
unambiguously phase 93.6% (1414 out of 1510) of all CNV regions and automatically deter-
mine the distribution of normal and deletion or duplication-carrying haplotypes in parents
and their offspring (Table 2; Figs 3 and 4). The unambiguous phasing efficiency was the highest
in group A of CNV regions, reaching 96.3% (1366 out of 1418; Table 2). All remaining CNV re-
gions (3.7%; 52 out of 1418) in group A were duplication CNV regions (CN3) containing
only uninformative monomorphic genotypes (e.g. ‘AA’ or ‘AAA’, etc.) or CNV probes that do
not interrogate any SNP variants. Subsequently, PiCNV was not able to unambiguously distin-
guish between exact maternal and paternal haplotypes and/or follow their transmission in off-
spring, resulting in several equally possible Mendelian transmissions in the corresponding
families (S2a Fig). Similar limitations were also observed in several CNV regions in groups B
and C resulting in unambiguous phasing in 60% and 33.3% of CNV regions in those groups, re-
spectively (Table 2). In groups B and C, higher phasing efficiency was observed for deletion
CNV loci and in larger families (data not shown). In the remaining CNV regions of groups B
and C, it was not possible to unambiguously determine the underlying haplotypes and/or fol-
low their transmission due to the combination of complex CNVs (multi-copy parental CNVs)
and/or presence of only uninformative SNP and CNV genotypes, resulting in several equally
possible Mendelian or non-Mendelian transmissions (e.g. de novo duplication or uniparental
heterodisomy) in the corresponding loci and families (S2b and S2d Fig).
Transmission of normal and CNV-carrying haplotypes
In order to determine the transmission rate of normal (cn = 1) and CNV-carrying (cn = 0 or
cn>1) haplotypes, we then analysed all 1366 CNV regions of HapMap YRI and EGCUT data-
sets in group A, where it was unambiguously possible to determine all parental haplotypes and
follow their segregation in the offspring (Fig 3). By counting the number of transmission events
of normal or CNV-carrying haplotypes from the parents carrying a CNV, we found that CNV-
carrying haplotypes had been transmitted slightly less frequently than normal haplotypes. In
the HapMap YRI dataset, 580 (46.4%) of such unambiguously phased transmission events cor-
responded to the inheritance of the CNV-carrying haplotype, whereas 671 (53.6%) of the trans-
missions involved the normal haplotype (p-value = 0.011). Similar trend was observed in the
EGCUT dataset with 70 (41.7%) transmissions of the variant-carrying haplotype and 98
(58.3%) events of inheritance of the normal haplotype (p-value = 0.037).
To further investigate this tendency, we analysed the transmission of normal and deletion/
duplication-carrying haplotypes (in HapMap YRI and EGCUT group A datasets combined)
while considering CNV length (Table 3). And although this analysis revealed small deviations
from the expected Mendelian transmission rate of 50% in nearly all CNV length intervals for
both deletions and duplications, the previously observed differences were mainly driven by the
under-transmission of short (<10kb) deletion-carrying haplotypes with transmission rate of
background) are filtered out. (C) Informative high-confidence genotypes are then phased considering all
family members simultaneously and the resulting haplotypes are presented as the result. (D) The family tree
of these phased haplotypes can be further visualised for the corresponding CNV region.
doi:10.1371/journal.pone.0122713.g002
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Fig 3. Examples of unambiguously phased CNV regions involving deletion- and duplication-carrying
haplotypes in families. (A) Inherited 820 kb-long deletion on chromosome 16:15369798–16190572 in
family T3. A deletion-carrying haplotype (cn = 0) is inherited from father (C010008) to son (Child 2, C010010).
The daughter (Child 1, C010011) has inherited normal haplotypes (cn = 1) from both parents. (B) Inherited
166 kb-long duplication on chromosome 10:47007374–47173619 in family T14. A duplication-carrying
CNV Haplotype Phasing in Families
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44.1%. Although statistically not significant, similar tendency of lower transmission rate was
observed for longer deletion-carrying haplotypes (range 45.7%- 48.1%, Table 3).
Allelic variability within variant-carrying haplotypes in CNV loci
There were 56 regions in YRI families and 9 regions in EGCUT families in group B, where both
parents had a CNV in the same locus (Table 2). These loci most likely represent common copy
number polymorphic (CNP) regions in Yoruban and Estonian populations. In the combined
dataset, in 34 (out of 39) unambiguously phased CNV loci both parents had a deletion-carrying
haplotypes in the same region. In two unambiguously phased CNV regions there were both de-
letion- and duplication-carrying haplotypes present in different parents of the same family
(e.g. 15q11.2 region in family Y045, S3 and S4 Figs) and in three regions both parents had du-
plication-carrying haplotypes (e.g. family Y004, S3 Fig), whereas in two of those regions there
were different duplication-carrying haplotypes with alternative allelic copies present.
The ability of PiCNV to phase and differentiate between normal and CNV-carrying haplo-
types with different allelic composition (Fig 1) allowed us to study the allelic variability within
the discovered copy number gain-carrying haplotypes more extensively. As alternative allelic
copies within CNV regions may modify severity of a phenotype including disease susceptibili-
ty, we aimed to determine the occurrence of alternative allelic copies withinmulti-copy haplo-
types. We combined and studied all CNV regions in both HapMap YRI and EGCUT datasets
in groups A and B where one or both parents of the same family had a duplication (cn = 2) or
triplication (cn = 3)-carrying haplotypes in the same locus. In 207 out of 222 (93.2%) of such
haplotype (cn = 2) is inherited from father (C010046) to one son (Child 1, C010049) and daughter (Child 2,
C010052). All other children have inherited normal haplotypes (cn = 1) from both parents. Coloured arrows
show the transmission of specific haplotypes from parents to offspring in a given CNV region. Respective B-
allele frequency (BAF, upper panel) and total fluorescent signal intensity (Log R Ratio—LRR, lower panel)
plots from Illumina Genome Viewer are shown next to the parents and each child.
doi:10.1371/journal.pone.0122713.g003
Table 1. Detailed description of analysed family-based SNPmicroarray datasets.
Dataset HapMap YRI EGCUT
Description Yoruba Nigerian family trios from the International HapMap
Project
Estonian families from population-based cohort from the Estonian
Genome Center
Total number of
families
30 34
Number of family
trios
30 22
Number of larger
families
- 8 quartets, 2 quintets, 1 sextet and 1 septet
Number of
individuals
90 121
Source of genomic
DNA
Lymphoblastoid cell lines Peripheral blood
SNP genotyping
platform
Illumina Human1M (from Itsara et al., Reference [49]) Illumina HumanCNV370K
Number of CNVs
called
4307 1088
CNV conﬁrmation Affymetrix custom high-resolution microarray data (from
Matsuzaki et al., Reference [52])
Visual conﬁrmation in Illumina Genome Viewer; qRT-PCR for 20
visually conﬁrmed CNV regions
Conﬁrmed CNVs
(CNVRs)
2067 (1364) 246 (146)
doi:10.1371/journal.pone.0122713.t001
CNV Haplotype Phasing in Families
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CNV regions in the combined dataset, informative polymorphic genotypes were present within
the multi-copy haplotypes and it was possible to phase and differentiate between distinct nor-
mal and multi-copy haplotypes (Table 4). Furthermore, in 138 out of 222 (66.7%) of these
CNV regions heterozygous genotypes were also present within the multi-copy haplotypes, al-
lowing to define alternative allelic copies within these copy number gain-carrying haplotypes
and demonstrating extensive allelic variability in multi-copy CNV regions in the human ge-
nome (Table 4 and S3 Fig).
Putative de novo copy number variants in HapMap YRI and EGCUT
families
In group C there were 27 CNVs (21 and 6 in HapMap YRI and EGCUT families, respectively)
that were identified as putative de novo copy number alterations in offspring (Table 2). Out of
these 27 putative de novo CNVs, 20 were deletions and 7 duplication events (S3 Table). As de-
termined by PiCNV algorithm and confirmed by manual inspection, in four (out of five) unam-
biguously phased de novo CNV regions in HapMap YRI families new variants appeared on
maternally and in one region on a paternally inherited chromosome. In EGCUT families, the
emergence of the new variant was detected on the maternally inherited chromosome in one
(out of four) unambiguously phased de novo CNV regions and on paternally inherited chromo-
somes in three regions (Fig 4).
Discussion
We have developed a computational algorithm PiCNV, that uses genotype and copy number
estimates from SNP genotyping data to determine the exact allelic composition and transmis-
sion of normal and copy number variable haplotypes in CNV regions in nuclear families. The
algorithm was tested in two independent family-based datasets typed on different genome-
wide SNP genotyping platforms.
Despite the decreasing sequencing costs and fast growing number of sequencing-based
studies, SNP genotyping microarrays are still extensively used in genetic studies of disease sus-
ceptibility and in clinical diagnostics. In addition to SNP variants, absolute copy number esti-
mates are often inferred from these genotyping datasets for genetic association studies.
Determination of distinct parental haplotypes and allelic variability of the haplotypes at CNV
regions in trios or larger nuclear families would specifically allow to study the transmission and
contribution of individual haplotypes (and allelic copies) to phenotypic traits, including
disease susceptibility.
Table 2. Unambiguously phased CNV regions in families.
Dataset HapMap YRI EGCUT Combined
All regions 94.4% (1287/1364) 87% (127/146) 93.6% (1414/1510)
Group A 97.2% (1251/1287) 87.8% (115/131) 96.3% (1366/1418)
Group B 55.4% (31/56) 88.9% (8/9) 60% (39/65)
Group C 23.8% (5/21) 66.7% (4/6) 33.3% (9/27)
Percentage of CNV regions in HapMap YRI and EGCUT families where PiCNV was automatically able to
unambiguously determine the underlying normal and CNV-carrying haplotypes in parents and follow their
transmission in offspring. Group A—CNV regions where only one parent had a CNV; group B—CNV
regions where both parents had a CNV in the same locus; group C—putative de novo CNV regions.
doi:10.1371/journal.pone.0122713.t002
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Fig 4. Examples of de novo copy-number variants in offspring. (A) De novo arisen 67 kb-long deletion on
chromosome 6:80596173–80663256 in family T39. Children 1–3 (C010135, C010136 and C010137) have
inherited one normal haplotype from both parents. One child (Child 4, C010138) has inherited one normal
haplotype from his mother (C010134) and a paternal haplotype with a de novo deletion event in the
corresponding region. (B) De novo arisen 167 kb-long duplication on chromosome 2:110175122–110331912
CNV Haplotype Phasing in Families
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To our knowledge, PiCNV is the first computational method that can deterministically
phase null, mono-, di-, tri- and tetraploid genotypes and infer the allelic composition within
normal and copy number gain-carrying haplotypes in CNV regions. PiCNV does not call
CNVs itself but works with widely used algorithms such as PennCNV (infer_snp_allele.pl),
QuantiSNP and Fawkes (from the Birdsuite package), that have specifically been developed for
CNV calling [33, 34, 47]. In addition to copy number estimates, these programs can infer the
total allelic composition at every genotyped marker within called CNVs which can be as accu-
rate as in case of conventional two-letter genotypes [33]. Similar to conventional phasing algo-
rithms that rely on two-letter SNP genotyping data [53–55], our algorithm uses the laws of
Mendelian inheritance to automatically resolve the haplotype distribution in a family by look-
ing at the allelic composition (SNP and CNV genotypes) of all family members and testing
through all possible allelic combinations for each studied CNV region. Contrary to other fami-
ly-aware phasing algorithms that avoid inheritance scenarios inconsistent with Mendelian in-
heritance [53, 56], PiCNV intentionally tries through the simplest non-Mendelian
transmission scenarios (de novo deletions and duplications of parental haplotypes, uniparental
iso- and heterodisomies), if the haplotype distribution cannot be explained by Mendelian in-
heritance scenarios. According to testing in HapMap YRI and EGCUT datasets, PiCNV can
unambiguously determine the haplotypes and inheritance scenario for vast majority of CNV
regions in families (93.6% of all CNV regions; Table 2). In case of complex CNV regions (e.g.
multiple CNV-carrying haplotypes in parents) or if only monomorphic markers are present
within a CNV region and the simplest haplotypes and Mendelian inheritance scenarios cannot
be applied to explain the allelic composition in all family members, PiCNV is unable to deter-
mine a single set of correct haplotypes and inheritance scenarios and it will suggest several
equally possible haplotypes and Mendelian and/or non-Mendelian transmissions (6.4% of all
CNV regions). Accordingly, in both analysed datasets we observed that haplotype phasing was
more efficient and resulted in one or very few equally possible parental haplotypes (and conse-
quent Mendelian and non-Mendelian transmission events) in CNV regions where only one
CNV-carrying haplotype was present in either parent (group A) compared to multiple CNV-
carrying haplotypes in parents (group B, e.g. S2b Fig) and de novo CNV regions (group C, e.g.
S2d Fig). And while the issue of multiple plausible Mendelian inheritance scenarios could be
in family T07. The only child (C010026) has inherited one normal haplotype from her mother (C010025) and a
paternal haplotype with a de novo intra-chromosomal duplication event in the corresponding region.
Coloured arrows show the transmission of specific haplotypes from parents to offspring in a given CNV
region. Respective B-allele frequency (BAF, upper panel) and total fluorescent signal intensity (Log R Ratio—
LRR, lower panel) plots from Illumina Genome Viewer are shown next to the parents and each child.
doi:10.1371/journal.pone.0122713.g004
Table 3. Transmission rate of deletion- and duplication-carrying haplotypes in HapMap YRI and EGCUT datasets combined.
CNV length Deletions (no of del/all) Duplications (no of dup/all) All CNVs (no of del+dup/all)
<10kb 44.1%* (279/632) 23.1% (6/26) 43.3* (285/658)
10–30kb 47.4% (137/289) 48.2% (27/56) 47.5% (164/345)
30–100kb 48.1% (101/210) 50% (27/54) 48.5% (128/264)
>100kb 45.7% (43/94) 51.7% (30/58) 48% (73/152)
All 45.7%* (560/1225) 46.4% (90/194) 45.8%* (650/1419)
*Statistically signiﬁcant (multiple-testing corrected p-value<0.05) deviations from the expected Mendelian transmission rate of 50%.
Transmission rate together with the number of transmitted variant-carrying haplotypes and the number of all transmission events (1 event/per locus/per
child) for each of the non-overlapping CNV length intervals.
doi:10.1371/journal.pone.0122713.t003
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possibly solved by genotyping and computationally phasing of additional first degree relatives
in the corresponding families, multiple equally possible non-Mendelian inheritance scenarios
could be avoided by prioritising non-Mendelian events by their theoretical or estimated
genomic frequencies.
In both datasets, we observed that CNV-carrying haplotypes were transmitted less frequent-
ly than normal haplotypes with the lowest rate (44.1%) detected for short (<10kb) deletion-
carrying haplotypes (Table 3). Although the phenomenon might be expected in case of some
high penetrance CNVs associated with severe disease phenotype, it has very briefly been inves-
tigated in healthy individuals [57, 58]. It has been suggested that such bias could be more pro-
nounced for larger deletion variants interrupting genes of vital importance, consequently being
more likely under stronger (prenatal) selection [1, 46, 49, 59–61]. Similar tendency was ob-
served for longer (>10kb) deletions-carrying haplotypes in this study (Table 3). The opposite
effect (even though statistically not significant) of slightly increased transmission rate of longer
(>100kb) duplications observed could possibly be explained by contribution of duplications in
providing means for functional redundancy [4, 62] and also in facilitating exon shuffling [63],
gene fusion and gene duplication [64–66]. By generating new functional genes, duplication
events may be important mechanism for long-term evolutionary changes in human and thus
under positive selection [1, 3, 9, 67–69]. However, only very cautious interpretation of these re-
sults should be considered and larger studies with high-resolution techniques are required to
confirm and further investigate these phenomena.
In addition to inherited variants PiCNV detected 27 putative de novo CNVs (Tables 2 and
S2). We say ‘putative’ because even if unambiguously phased and validated by other experi-
mental methods, such variants might be not true germline de novo mutations but instead so-
matically deriving cloned mutations or artefacts often observed in cell-line material [49, 70–
72]. De novo CNVs might also ‘appear’ due to complex haplotype composition of a studied
family in a given locus, e.g. in CNP loci [59, 73] where haplotypes with 0 and 2 copies are com-
bined in one parent (e.g. 2q34 region in individual NA19092, S4 Fig) leading to incorrect call-
ing of de novo variants from unphased CNV data and thus highlighting the relevance of
phasing of the exact parental haplotypes. Additionally, similarly to the approach used by Kirov
and colleagues [74], in the presence of haplotype-informative SNPs, PiCNV can determine on
which parental chromosome the de novo aberration had occurred and in case of duplications,
whether the event was inter- or intra-chromosomal (Fig 4b).
Deterministic phasing of haplotypes in families allowed us to elucidate the allelic variability
within copy number variable loci. We found that in the majority of copy number gain regions
it was possible to accurately determine and differentiate the alternative allelic copies between
the single-copy and multi-copy haplotypes and also within the multi-copy haplotypes,
Table 4. CNV regions in HapMap YRI and EGCUT parents where allelic variability between and within normal and copy number gain-carrying hap-
lotypes can be deterministically differentiated.
Dataset
Haplotypes HapMap YRI EGCUT Combined
Total number of copy number gain-carrying haplotypes in families 162 60 222
Informative markers present between normal and copy number gain-carrying haplotypes 92% (149) 96.7% (58) 93.2% (207)
Informative markers present within copy number gain-carrying haplotypes 59.7% (89) 84.5% (49) 66.7% (138)
In case informative polymorphic genotypes are present between haplotypes in an individual, copy number gain-carrying haplotypes (cn>1) can be
deterministically distinguished from the normal single copy haplotypes (cn = 1). Furthermore, these informative genotypes can be used to establish the
allelic composition and different allelic copies within copy number gain-carrying haplotypes.
doi:10.1371/journal.pone.0122713.t004
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suggesting a relatively wide variability in allelic composition within copy number gain CNVs
(Table 4). Such true ‘CNV genotyping’, determination of the exact allelic composition within
CNV regions, is necessary considering that many CNVs credibly associated with disease phe-
notypes are multi-allelic [5, 19, 75]. Alternative allelic copies present within CNV regions can
modulate the severity of a given disease phenotype, partly explaining the low penetrance of
most CNV loci (especially duplications) associated with disease so far.
In summary, we have developed a novel algorithm PiCNV, enabling to accurately determine
the haplotype and allelic composition of CNV regions in family-based SNP genotyping data-
sets. The algorithm proved as a valuable tool to resolve the haplotype distribution in CNV re-
gions and to follow the transmission of distinct haplotypes in offspring. Phased haploid copy
number estimates (together with known parent-of-origin information) and the exact allelic
composition of each haplotype allows to look ‘inside’ the CNVs and explicitly consider differ-
ent allelic copies present in all studied individuals (e.g. cases and controls). Determination of
allelic composition within CNVs provides new possibilities for studying CNVs in association
with different phenotypic traits, including disease.
Materials and Methods
EGCUT cohort
All participants of this study were adult individuals from the Estonian population-based cohort
[76] with no reported severe developmental disorders. All participants gave written informed
consent and the study was approved by the Research Ethics Committee of University of Tartu.
DNA extracted from peripheral blood was obtained from the Estonian Genome Center of Uni-
versity of Tartu (Tartu, Estonia; www.biobank.ee/en). These samples were genotyped by using
Illumina (San Diego, CA, USA) Infinium HumanCNV370 chips at the Estonian Biocentre
Genotyping Core Facility (Tartu, Estonia) according to the manufacturer's instructions. Raw
microarray data was scanned with Illumina BeadStation and data normalisation was performed
with the Illumina GenomeStudio software.
Data for the YRI HapMap cohort
Illumina (San Diego, CA, USA) Infinium Human1M-Duo normalised microarray data gener-
ated by Itsara et al. [49] for 30 Yoruba Nigerian mother-father-child trios from the Internation-
al HapMap Project [50, 51] were downloaded from NCBI Gene Expression Omnibus (http://
www.ncbi.nlm.nih.gov/geo, GEO accession no GSE16896).
CNV calling and filtering
Normalised microarray signal intensity data for both cohorts was analysed with PennCNV
[47] (2009Aug27 v.) and QuantiSNP [33] (v.2) programs to call putative CNVs in each individ-
ual. Settings and parameters suggested by authors were used for both algorithms together with
the ‘genomic wave’ adjustment for the signal intensity data. Additionally, with PennCNV we
used separate B allele-frequency files (PFB-file) for both datasets—for the EGCUT dataset we
used general Estonian population-based dataset [76] as the reference (n = 1000) and for Hap-
Map YRI we used PennCNV’s default PFB-file based on HapMap samples. As a quality control
measure, we checked that all samples met the following quality criteria calculated by the
PennCNV program: LRR_SD0.25, BAF_SD0.05, BAF_DRIFT0.002 and GCWF|0.04|.
Raw CNV calls from PennCNV and QuantiSNP were then merged (as intersection, for each in-
dividual separately) with custom PERL script and only CNVs that were similarly called (same
type of overlapping copy number change—gain or loss) were considered. As CNV calls from
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one algorithm can possibly have many false positive calls, considering only CNVs called by
more than one independent algorithm will minimise the number of false positive CNVs
[77–79]. From the resulting list of CNVs we filtered out CNVs i) called on X/Y chromosomes;
ii) shorter than 1000 bp in length; iii) with QuantiSNP log Bayes Factor (LBF) less than 5.
Throughout this study we used the NCBI Build 36/hg18 assembly coordinates of the human
reference sequence.
CNV confirmation in the HapMap YRI dataset
In order to achieve high-quality CNV dataset, we confirmed our HapMap YRI CNV calls with
an independent set of validated CNV calls for the same HapMap YRI individuals. CNV calls
generated and confirmed with custom Affymetrix (Emeryville, CA, USA) high-resolution mi-
croarrays (with 32 million unique oligonucleotide probes for CNV discovery and 800,000
unique probes for CNV confirmation) by Matsuzaki et al. [52] were downloaded from http://
genomebiology.com/2009/10/11/R125/additional. CNVs called by us and CNVs called and
confirmed by Matsuzaki et al. [52] were compared for each individual separately (custom
PERL script) and only CNVs that were called in both datasets were considered for
further analyses.
Visual confirmation in the EGCUT dataset
To ensure high-quality of the EGCUT CNV dataset, CNVs detected by PennCNV and Quan-
tiSNP algorithms were further visually confirmed with Illumina Genome Viewer. For each
CNV locus, signal intensity data for all corresponding family members was loaded simulta-
neously and visually inspected to confirm CNV calls and family members with no CNV call.
CNV regions containing no visually detectable CNVs (or CNVs not called but visually distin-
guishable) were excluded from the further analyses.
Converging CNV regions in families
All technically/visually confirmed CNVs were then converged into distinct CNV regions in
families. We excluded those family-wise CNV regions in which any member of the correspond-
ing family had any raw (unfiltered) CNV calls made by only one calling algorithm (custom
PERL script), so that in each resulting CNV region at least one member of the respective family
had a confirmed CNV while family members with normal diploid copy number (CN = 2) were
proven to have no variant calls made by neither of the calling algorithms in the given region.
Experimental validation of CNVs in the EGCUT dataset
In the EGCUT dataset (for which the DNAs were available to us), 20 CNV regions were select-
ed for experimental validation by quantitative real-time PCR (qRT-PCR) in all members of the
respective families (S1 Table). First, we randomly selected 12 loci where in the corresponding
families at least one parent had a CNV call. Additionally, all eight putative de novo CNV re-
gions were selected for validation. Considering all parents and siblings in the corresponding
nuclear families, that summed up to 94 qRT-PCR assays. Out of those, 34 were regions with vi-
sually confirmed CNVs and 60 were regions with visually confirmed normal diploid copy
number (CN = 2) in assumingly CNV-less members of the corresponding families. DNA sam-
ples of corresponding families were obtained from the Estonian Genome Center of University
of Tartu. QRT-PCR primers were designed with the qRTDesigner tool (http://bioinfo.ut.ee/
qrtdesigner) within each selected region. Universal controls with confirmed diploid copy num-
ber of two were used in each validation assay. QRT-PCR reactions were performed in a total
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volume of 10 μl consisting of 5× Hot FIREPol EvaGreen qPCR mix (Solis BioDyne), 10 ng of
genomic DNA and 200–400 nM primers. Triplicate single-plex reactions were run on ABI
Prism 7900HT real-time PCR system (Applied Biosystems) using the following amplification
conditions: denaturation at 95°C for 15 min, followed by 40 cycles of denaturation at 95°C for
15 s, annealing at 60°C for 20 s and elongation at 72°C for 20 s. Absolute quantitation results
were normalised to internal standard gene ALB and a reference DNA pool compiled of unrelat-
ed Estonian samples (n = 50). Out of 20 loci selected, four loci failed due to unsuccessful primer
design. In total (also considering de novo CNV loci), out of 76 validated regions, 20 individual
CNV calls were proven to be true positives. Out of these, 15 were deletions and 5 were duplica-
tions. 48 loci were proven to be true negatives, i.e. there were no CNVs in those regions in the
corresponding family members and those regions were confirmed to have expected normal
diploid copy number (CN = 2). Six regions were proven to be false positives and two as false
negatives and these CNV loci were excluded from the subsequent analysis.
Computational phasing of CNV regions in families
As the first step, regular two-letter and CNV genotypes were collected from the QuantiSNP
output for each family member at each CNV region. If there were several individuals in the
family with a CNV in the analysed region, the intersection region of these individual CNV calls
was used (requiring at least 3 ‘shared’markers) and markers that were not part of the consecu-
tive CNV region observed in each family member with a CNV call were discarded. Next, mark-
ers that had low-confidence genotype calls (regular genotype/CNV genotype call probability
<0.95) or where the call could not have been made (‘NC’ genotypes) and markers that did not
have informative genotypes for haplotype phasing in the studied region were filtered out. Next,
PiCNV generated the comprehensible list of all possible elementary inheritance events for all
mother-father-child trios for all markers in a given CNV region. An elementary inheritance
event describes unambiguously both the allelic composition of a given marker in parent geno-
type and how specific haplotypes from both parents combine and produce the genotype of a
zygote, additionally to possible Mendelian transmissions also allowing the simplest non-Men-
delian events (de novo deletions and duplications and uniparental iso- and heterodisomies).
Next, a three-step algorithm was used. Firstly, the best combination of haplotypes in both pa-
rents was searched by minimising the number of unexplainable genotypes and the number of
non-Mendelian events in children. Secondly, the best gamete formation schemes in each family
were searched, also by minimising the number of unexplainable genotypes and the number of
non-Mendelian events in children. Gamete formation scheme describes unambiguously how
allele(s) in one parent form the genotype of a gamete (haplotype) by unmodified transmission
of parental allele(s). As in case of Mendelian transmissions, considered non-Mendelian events
in a gamete formation had to be consistent for all genotypes within a CNV for each mother-
father-child trio, but could vary between different parents-child trios if more than one child
was available. Finally, the best phased genotype(s) for each marker that were consistent with al-
lelic combination and gamete formation were searched, also minimising the number of unex-
plainable genotypes and the number of non-Mendelian events in a given family and presented
as the result. If there were no haplotype-informative markers within a CNV region and the
simplest haplotypes and Mendelian inheritance scenarios did not explain the allelic composi-
tion in all family members, it was not possible to determine a single set of correct haplotypes
and inheritance scenarios and several equally possible haplotypes and Mendelian and/or non-
Mendelian transmissions were suggested as the result.
On an Intel Xeon 2.27GHz computer (running 64-bit CentOS Linux) the whole procedure
took about 2 minutes (using 2.5GB of RAM) for 34 EGCUT families genotyped on low-resolution
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Illumina HumanCNV370K array and less than 9 minutes (max 6.4GB of RAM) for 30 HapMap
YRI trios genotyped on high-resolution Illumina Human1M array.
Transmission of normal and CNV-carrying haplotypes
This analysis was carried out only in unambiguously phased CNV regions in group A. We de-
cided not to include the small number of unambiguously phased CNV regions in group B for
several reasons: i) to keep the transmission analysis as straightforward as possible; ii) if both
haplotypes in one (or both) parents are variant-carrying, inheritance of normal haplotypes is
not possible at all; iii) overall phasing efficiency in group B was much lower compared to group
A. In each unambiguously phased CNV region in group A we counted the number of transmis-
sions of normal and CNV-carrying haplotypes from the parents carrying a CNV to their off-
spring and these counts were summed over all CNV regions in the combined dataset. This was
repeated for deletion and duplication CNV loci separately, also considering their length. Devi-
ance from the expected 50:50 transmission (no preference in inheritance of normal or CNV-
carrying haplotypes) was tested with the Pearson’s chi-square test in the statistical package R
(ver. 2.13.0; http://www.R-project.org).
Allelic variability within copy number variant-carrying haplotypes
Unambiguously phased parental haplotypes in CNV regions where one (group A) or both
(group B) parents of the same family had a duplication (cn = 2) or triplication (cn = 3)-carrying
haplotypes were studied. For each respective CNV region and parent, the number of polymor-
phic (normal and CNV) genotypes present between the normal and copy number gain-carry-
ing haplotypes (e.g. SNP2 and SNP3; Fig 1) and within the copy number gain-carrying
haplotypes (e.g. SNP7; Fig 1) was calculated. If there were one or more polymorphic genotypes
present within the copy number gain-carrying haplotypes, the corresponding alleles were con-
sidered as different and if there were no polymorphic genotypes present, the corresponding al-
leles were considered to be identical.
Supporting Information
S1 Fig. Step-by-step description of data analysis and filtering steps. Based on the occur-
rences of CNVs in parents in every family, all CNV regions and corresponding transmission
events were divided into three groups: group A—CNV regions where in any given region only
one parent had a CNV (marked as ‘X’ on illustrative homologous chromosomes) that might or
might not have been transmitted (marked as ‘?’) to offspring; group B—CNV regions and
transmission events where both parents had a CNV in the same locus that might or might not
have been transmitted to their offspring; group C—putative de novo CNVs where parents did
not have any CNVs, but at least one child had a CNV in the corresponding locus.
(TIF)
S2 Fig. Examples of copy number gain and de novo CNV regions for which unambiguous
phasing of exact parental haplotypes and/or following their transmission in offspring was
not automatically possible, resulting is several equally possible transmission scenarios. (A)
A 69 kb-long duplication region on chromosome 2 in family T06 that (due to two equally pos-
sible paternal haplotype combinations and corresponding transmission scenarios) was not un-
ambiguously phased. Paternal genotypes that can be distributed differently on two distinct
combinations of paternal haplotypes are indicated with dashed rectangles. (B) A 10 kb-long
multi-copy CNV region on chromosome 10. In case there are only monomorphic uninforma-
tive genotypes present in parents (e.g. family Y005), several equally possible haplotype
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configurations and Mendelian transmission scenarios are possible. (C) In case there are haplo-
type-informative genotypes present in parents (as for the same CNV region in families Y105
and Y042), it is possible to determine the exact parental haplotypes and follow their transmis-
sion in the offspring. (D) A family with a 103 kb-long de novo deletion on chromosome 1
found in an offspring. Due to undistinguishable haplotypes in parents it is not possible to de-
termine, on which parental chromosome the de novo deletion has occurred.
(TIF)
S3 Fig. A 155 kb-long copy number polymorphic (CNP) region on chromosome
15:19811954..19967627 with normal and both deletion- and duplication-carrying haplo-
types. Considering the allelic composition within these duplication-carrying haplotypes, sever-
al different allelic copies seem to be present within this region. Heterozygous genotypes within
the duplication-carrying haplotypes that enable distinguishing the allelic copies within these
haplotypes are indicated with dotted rectangle.
(TIF)
S4 Fig. An interesting CNV region at chromosome 2:213922542..213939290. In family
Y040, the mother has a 17 kb-long copy number gain (diploid copy number CN = 4) and the
father has normal diploid copy number (CN = 2) in the same locus. Interestingly, their child
had a copy number gain with diploid copy number of four (CN = 4). Given the allelic composi-
tion within that CNV region in this family, the only appropriate Mendelian inheritance scenar-
io was proposed whereby the child had inherited a duplication-carrying haplotype from her
mother and also from her father. This is demonstrating a highly polymorphic CNV locus with
0, 1 and 2 copies (including several different allelic copies) present on homologous chromo-
somes and haplotypes with 2 and 0 copies combined in the corresponding father.
(TIF)
S1 Table. Quantitative real-time PCR validation results.
(XLSX)
S2 Table. Putative de novo CNVs in HapMap YRI and EGCUT families.
(XLSX)
S3 Table. List of analysed CNV regions in HapMap YRI and EGCUT families together with
the phasing and haplotype information (PiCNV output) for each family member.
(XLSX)
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